First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a First Trust ETF with a 0.60% expense ratio, 51 holdings and $1.1B in net assets. Largest sector: Healthcare (100%).
Fee
0.60%
expense ratio
Net assets
$1.1B
Launched
Sep 20, 2016
Holdings
51
as of Oct 23, 2026
Top 10 weight
55.1%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 0.81% · TTM 0.70%
as of Sep 30, 2026
Benchmark
—
FTXH's holdings are as of Oct 23, 2026.
Healthcare
100.0%
1
ABBV
ABBVIE
7.74%
2
LLY
ELI LILLY
7.65%
3
PFE
PFIZER
7.33%
4
JNJ
JOHNSON + JOHNSON
6.89%
5
MRK
MERCK
6.83%
6
BIIB
BIOGEN
4.02%
7
VTRS
VIATRIS
3.79%
8
GILD
GILEAD SCIENCES
3.70%
9
ZTS
ZOETIS
3.65%
10
AMGN
AMGEN
3.55%
11
UTHR
United Therapeutics
3.55%
12
REGN
REGENERON PHARMACEUTICALS
3.50%
13
VRTX
VERTEX PHARMACEUTICALS
3.34%
14
INCY
INCYTE
3.23%
15
BMY
BRISTOL-MYERS SQUIBB
3.20%
16
EXEL
Exelixis
2.50%
17
JAZZ
Jazz Pharmaceuticals
2.36%
18
ILMN
ILLUMINA
2.16%
19
HALO
Halozyme Therapeutics
1.75%
20
MEDP
Medpace Holdings
1.60%
21
NBIX
Neurocrine Biosciences
1.17%
22
CRL
CHARLES RIVER LABORATORIES
1.16%
23
BMRN
BioMarin Pharmaceutical
1.14%
24
ELAN
Elanco Animal Health
1.12%
25
ALNY
Alnylam Pharmaceuticals
1.11%
1–25 of 51
Funds listed by how much of their largest holdings they share with FTXH — not a ranking.
Data from First Trust; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.